FI955587A - Chemical compounds - Google Patents

Chemical compounds Download PDF

Info

Publication number
FI955587A
FI955587A FI955587A FI955587A FI955587A FI 955587 A FI955587 A FI 955587A FI 955587 A FI955587 A FI 955587A FI 955587 A FI955587 A FI 955587A FI 955587 A FI955587 A FI 955587A
Authority
FI
Finland
Prior art keywords
chemical compounds
compounds
chemical
Prior art date
Application number
FI955587A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI955587A0 (en
Inventor
Peter Clive Cherry
John Derek Cocker
Andrew David Searle
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of FI955587A0 publication Critical patent/FI955587A0/en
Publication of FI955587A publication Critical patent/FI955587A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
FI955587A 1993-05-21 1995-11-20 Chemical compounds FI955587A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939310635A GB9310635D0 (en) 1993-05-21 1993-05-21 Chemical compounds
PCT/EP1994/001613 WO1994027989A1 (en) 1993-05-21 1994-05-19 Carbazole derivatives with 17,20-lyase-inhibiting activity

Publications (2)

Publication Number Publication Date
FI955587A0 FI955587A0 (en) 1995-11-20
FI955587A true FI955587A (en) 1995-11-20

Family

ID=10736007

Family Applications (1)

Application Number Title Priority Date Filing Date
FI955587A FI955587A (en) 1993-05-21 1995-11-20 Chemical compounds

Country Status (19)

Country Link
EP (1) EP0699196A1 (en)
JP (1) JPH08510455A (en)
CN (1) CN1126473A (en)
AU (1) AU6928794A (en)
BG (1) BG100154A (en)
CA (1) CA2162921A1 (en)
CZ (1) CZ305195A3 (en)
FI (1) FI955587A (en)
GB (1) GB9310635D0 (en)
HU (1) HUT73790A (en)
IL (1) IL109703A0 (en)
NO (1) NO954681D0 (en)
OA (1) OA10195A (en)
PE (1) PE31195A1 (en)
PL (1) PL311702A1 (en)
SK (1) SK142495A3 (en)
TW (1) TW279866B (en)
WO (1) WO1994027989A1 (en)
ZA (1) ZA943494B (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT75871A (en) * 1993-09-30 1997-05-28 Yamanouchi Co Azole derivatives and pharmaceutical compositions thereof
AU3846395A (en) * 1994-11-07 1996-05-31 Janssen Pharmaceutica N.V. Compositions comprising carbazoles and cyclodextrins
CN1177350A (en) * 1995-03-01 1998-03-25 山之内制药株式会社 Imidazole derivatives and medicinal composition thereof
CN1251577A (en) * 1997-02-21 2000-04-26 武田药品工业株式会社 Fused ring compounds, process for producing same and use thereof
CN100572363C (en) 2000-11-17 2009-12-23 武田药品工业株式会社 Imdazole derivatives, Its Preparation Method And Use
ATE502030T1 (en) 2000-11-20 2011-04-15 Takeda Pharmaceutical IMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE
DE60139639D1 (en) 2000-12-08 2009-10-01 Takeda Pharmaceutical SUBSTITUTED THIAZONE DERIVATIVES WITH 3-PYRIDYL GROUPS, PROCESS FOR THEIR PREPARATION AND THEIR USE
EP1902026B1 (en) 2005-06-24 2010-02-17 Eli Lilly And Company Tetrahydrocarbazole derivatives useful as androgen receptor modulators (sarm)
US8093279B2 (en) 2005-12-13 2012-01-10 Gillian Reed, legal representative Compound
GB0525323D0 (en) * 2005-12-13 2006-01-18 Sterix Ltd Compound
CN100586932C (en) * 2007-01-26 2010-02-03 中国医学科学院医药生物技术研究所 Antitumor compound and its preparation process
UA105794C2 (en) 2009-06-26 2014-06-25 Новартіс Аг 1,3-DISUBSTITUTED IMIDAZOLIDIN-2-ONE DERIVATIVES AS Cyp17 INHIBITORS
AU2011212813B2 (en) * 2010-02-04 2014-10-23 Radius Health, Inc. Selective androgen receptor modulators
ME02474B (en) 2010-05-12 2017-02-20 Radius Health Inc Therapeutic regimens
US9132105B2 (en) 2010-08-04 2015-09-15 Pellficure Pharmaceuticals, Inc. Treatment of prostate carcinoma
US8946260B2 (en) 2010-09-16 2015-02-03 Novartis Ag 17α-hydroxylase/C17,20-lyase inhibitors
EP2621901B1 (en) 2010-09-28 2015-07-29 Radius Health, Inc Selective androgen receptor modulators
ES2656218T3 (en) 2011-04-28 2018-02-26 Novartis Ag 17 alpha-hydroxylase / C17,20-lyase inhibitors
US9492460B2 (en) * 2013-02-27 2016-11-15 Bristol-Myers Squibb Company Carbazole compounds useful as bromodomain inhibitors
CA2902335C (en) 2013-03-14 2021-09-14 Pellficure Pharmaceuticals, Inc. Novel therapy for prostate carcinoma
US9421264B2 (en) 2014-03-28 2016-08-23 Duke University Method of treating cancer using selective estrogen receptor modulators
DK3122426T3 (en) 2014-03-28 2023-04-03 Univ Duke Treatment of breast cancer using selective estrogen receptor modulators
US10093620B2 (en) 2014-09-12 2018-10-09 Pellficure Pharmaceuticals, Inc. Compositions and methods for treatment of prostate carcinoma
LT3474841T (en) 2016-06-22 2022-06-10 Ellipses Pharma Ltd Ar+ breast cancer treatment methods
EP3528799A1 (en) 2016-10-24 2019-08-28 Pellficure Pharmaceuticals, Inc. Pharmaceutical compositions of 5-hydroxy-2-methylnaphthalene-1, 4-dione
PL3565542T3 (en) 2017-01-05 2024-07-29 Radius Pharmaceuticals, Inc. Polymorphic forms of rad1901-2hcl

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS229934B2 (en) * 1981-07-07 1984-07-16 Pfizer Production method subst.indolylacryte acid derivative
GB8518743D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds

Also Published As

Publication number Publication date
BG100154A (en) 1996-07-31
TW279866B (en) 1996-07-01
OA10195A (en) 1996-12-18
PE31195A1 (en) 1995-10-18
AU6928794A (en) 1994-12-20
PL311702A1 (en) 1996-03-04
CN1126473A (en) 1996-07-10
ZA943494B (en) 1995-01-23
FI955587A0 (en) 1995-11-20
NO954681L (en) 1995-11-20
GB9310635D0 (en) 1993-07-07
JPH08510455A (en) 1996-11-05
EP0699196A1 (en) 1996-03-06
IL109703A0 (en) 1994-08-26
WO1994027989A1 (en) 1994-12-08
HUT73790A (en) 1996-09-30
SK142495A3 (en) 1996-06-05
NO954681D0 (en) 1995-11-20
CZ305195A3 (en) 1996-06-12
CA2162921A1 (en) 1994-12-08
HU9503321D0 (en) 1996-01-29

Similar Documents

Publication Publication Date Title
BG96392A (en) CHEMICAL COMPOUNDS
FI955587A (en) Chemical compounds
MX9101375A (en) CHEMICAL COMPOUNDS
BR1101108A (en) Compound
ID15985A (en) CHEMICAL COMPOUND
DK72693D0 (en) COMPOUNDS
MX9202262A (en) CHEMICAL COMPOUNDS.
NO951433D0 (en) Chemical connections
FI945907A0 (en) Chemical compounds
FI932571A0 (en) Chemical process
DK124393D0 (en) COMPOUNDS
FI944825A0 (en) Phenylbenzoamide - based fungicidal compounds
DE59409946D1 (en) Anti-droning compounds.
FI961520A (en) Heribicidal azabisphosphonic acid compounds
KR970707090A (en) 18-Nor-Vitamin D Compounds
NO962264D0 (en) Chemical connections
MX9205851A (en) CHEMICAL COMPOUNDS
NO953697D0 (en) Chemical process
DK244090D0 (en) CHEMICAL COMPOUNDS
ITRM940566A0 (en) ORGANIC COMPOUNDS
DK150591D0 (en) CHEMICAL COMPOUND
DK85393D0 (en) CHEMICAL COMPOUND
DK39992D0 (en) CHEMICAL COMPOUNDS
DK102693D0 (en) NOVEL COMPOUNDS
KR950013225U (en) Distiller

Legal Events

Date Code Title Description
FD Application lapsed